Cingulate (CING) vs OS Therapies (OSTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cingulate (CING) has outperformed OS Therapies (OSTX) over the past year, gaining 17.3% versus a loss of 24.0%. OS Therapies is the larger company by market cap ($72.5 million vs $70.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CING | OSTX |
|---|---|---|
| Share price | $4.87 | $1.55 |
| Market cap | $70.82M | $72.55M |
| 1-day change | -0.41% | +4.03% |
| YTD return | +12.21% | +10.71% |
| 1-year return | +17.35% | -24.02% |
| Forward P/E | — | 4.47 |
| EPS (TTM) | $-3.51 | $-1.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.89 | $2.25 |
| 52-week low | $3.16 | $1.15 |
| Distance from 52-week high | -59.04% | -31.11% |
| Average volume | 150.39K | 597.43K |
| Shares outstanding | 14.54M | 46.81M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CING has outperformed OSTX by 41.4 percentage points over the past year.
CING vs OSTX FAQ
Which is bigger, Cingulate or OS Therapies?
OS Therapies (OSTX) is larger, with a market capitalization of $72.55M compared with $70.82M for Cingulate (CING).
Which stock has performed better over the past year, CING or OSTX?
CING returned +17.35% over the past 12 months, compared with -24.02% for OSTX (price return, excluding dividends). Past performance does not predict future results.
Are Cingulate and OS Therapies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.